Effect of radiation and paclitaxel on p53 expression in murine tumors sensitive or resistant to apoptosis induction

International Journal of Radiation Oncology Biology Physics

Volumn 38, Issue 3, 1997, Pages 623-631

  Saito, Yoshihiro ^a   Milross, Christopher G ^c   Hittelman, Walter N ^b   Li, Donghui ^b   Jibu, Tatsuo ^c   Peters, Lester J ^d   Milas, Luka ^b,c  

^a GUNMA UNIVERSITY   (Japan)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Apoptosis; Chemoresponse; p53; Paclitaxel; Radioresponse; Tumor

Indexed keywords

CISPLATIN; FLUOROURACIL; PACLITAXEL; PROTEIN P21; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL DESTRUCTION; CANCER RADIOTHERAPY; CONTROLLED STUDY; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 0030825492     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)89488-6     Document Type: Article

References (34)

1. Brugarolas, J.; Chandrasekaran, C.; Gordon, J. I.; Beach, D.; Jacks, T.; Hannon, G. J. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377:552-557; 1995.
2. Choy, H.; Rodriguez, F. F.; Koester, S.; Hilsenbeck, S.; Von Hoff, D. D. Investigation of taxol as a potential radiation sensitizer. Cancer 71:3774-3778; 1993.
3. CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82:675-684; 1995.
4. Kastan, M. B.; Canman, C. E.; Leonard, C. J. P53, cell cycle control and apoptosis: Implications for cancer. Cancer Metastasis Rev. 14:3-15; 1995.
5. Korsmeyer, S. J. Bcl-2: A repressor of lymphocyte death. Immunol. Today 13:285-288; 1992.
6. Liebmann, J.; Cook, J. A.; Fisher, J.; Teague, D.; Mitchell, J. B. Changes in radiation survival curve parameters in human tumor and rodent cells exposed to paclitaxel (Taxol). Int. J. Radiat. Oncol. Biol. Phys. 29:559-564; 1994.
7. Liu, T. J.; Zhang, W. W.; Taylor, D. L.; Roth, J. A.; Goepfert, H.; Clayman, G. L. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res. 54:3662-3667; 1994.
8. Lowe, S. W.; Ruley, H. E.; Jacks, T.; Housman, D. E. p-53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957-967; 1993.
9. Meyn, R. E.; Stephens, L. C.; Ang, K. K.; Hunter, N. R.; Brock, W. A.; Milas, L.; Peters, L. J. Heterogeneity in the development of apoptosis in irradiated murine tumours of different histologies. Int. J. Radiat. Biol. 64:583-591; 1993.
10. Milas, L.; Hunter, N. R.; Kurdoglu, B.; Mason, K. A.; Meyn, R. E.; Stephens, L. C.; Peters, L. J. Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with Taxol (paclitaxel). Cancer Chemother. Pharmacol. 35:297-303; 1995.
11. Milas, L.; Hunter, N. R.; Mason, K. A.; Kurdoglu, B.; Peters, L. J. Enhancement of tumor radioresponse of a murine mammary carcinoma by Taxol. Cancer Res. 54:3506-3510; 1994.
12. Milas, L.; Hunter, N. R.; Mason, K. A.; Milross, C. G.; Saito, Y.; Peters, L. J. Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel. Cancer Res. 55:3564-3568; 1995.
13. 3Hf/Bu mice bearing syngeneic fibrosarcoma of different sizes. Cancer Res. 34:61-71; 1974.
14. Milross, C. G.; Mason, K. A.; Hunter, N. R.; Chung, W.-K.; Peters, L. J.; Milas, L. Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel. JNCI 88:1308-1314, 1996.
15. Minarik, L.; Hall, E. J. Taxol in combination with acute and low dose rate irradiation. Radiother. Oncol. 32:124-128; 1994.
16. L and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage. Genes Dev 10:2621-2631; 1996.
17. Oltvai, Z. N.; Milliman, C. L.; Korsmeyer, S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programed cell death. Cell 74:609-619; 1993.
18. Rich, T. A.; Terry, N. H. A.; Meistrich, M. L. Chemoradiotherapy for anal and rectal carcinomas. Cancer Bull 46:322-325; 1994.
19. Rosell, R.; Gonzalez-Larriba, J. L.; Alberola, V.; Molina, F.; Monzo, M.; Benito, D.; Perez, J. M.; de Anta, J. M. Single-agent paclitaxel by 3-hour infusion in the treatment of non-small cell lung cancer: links between p53 and K-ras gene status and chemosensitivity. Semin Oncol 22:12-18; 1995.
20. Rowinsky, E. K.; Onetto, N.; Canetta, R. M.; Arbuck, S. G. Taxol: the first of the taxanes, an important new class of antitumor agents. Semin. Oncol. 19:646-662; 1992.
21. Schiff, P. B.; Fant, J.; Horwitz, S. B. Promotion of microtubule assembly in vitro by taxol. Nature (Lond.) 277:665-667; 1979.
22. Schiff, P. B.; Horwitz, S. B. Taxol stabilizes microtubules in mouse fibroblast cells. Proc. Natl. Acad. Sci. USA 77:1561-1565; 1980.
23. Stephens, L. C.; Ang, K. K.; Schultheiss, T. T.; Milas, L.; Meyn, R. E. Apoptosis in irradiated murine tumors. Radiat. Res. 127:308-316; 1991.
24. Steren, A.; Sevin, B. U.; Perras, J.; Angiolo, R.; Nguyen, H.; Guerra, L.; Koechli, O.; Averette, H. E. Taxol sensitizes human ovarian cancer cells to radiation. Gynecol. Oncol. 48:252-258; 1993.
25. Stromberg, J. S.; Lee, Y. J.; Armour, E. P.; Martinez, A. A.; Corry P. M. Lack of radiosensitization after paclitaxel treatment of three human carcinoma cell lines. Cancer 75:2262-2268; 1995.
26. Suit, H.; Allam, A.; Allalunis-Turner, J.; Brock, W.; Girinsky, T.; Hill, S.; Hunter, N.; Milas, L.; Pearcey, R.; Peters, L.; Welch, D. R.; West, C.; Effird, J. Is tumor cell radiation resistance correlated with metastatic ability? Cancer Res. 54:1736-1741; 1994.
27. Terry, N. H. A.; Milross, C. G.; Patel, N.; Milas, L. Flow-cytometric measurement of apoptosis and tumor cell kinetics following treatment with taxol. (Abstr.) In: Book of Abstracts of the 43rd Annual Meeting of the Radiation Research Society, p. 266, 1995.
28. Tishler, R. B.; Geard, C. R.; Hall, E. J.; Schiff, P. B. Taxol sensitizes human astrocytoma cells to radiation. Cancer Res. 52:3495-3497; 1992.
29. Tishler, R. B.; Lampus, D. M.; Park, S.; Price, B. D. Microtubule-active drugs taxol, vinblastine, and nocodazole increase the levels of transcriptionally active p53. Cancer Res. 55:6021-6025; 1995.
30. Wahl, A. F.; Donaldson, K. L.; Fairchild, C.; Lee, F. Y. F.; Foster, S. A.; Demers, G. W.; Galloway, D. A. Loss of normal p53 function confers sensitization to taxol by increasing G2/M arrest and apoptosis. Nat Med 2:72-79; 1996.
31. White, E. Life, death, and the pursuit of apoptosis. Genes Dev 10:1-15; 1996.
32. Woods, C. M.; Zhu, J.; McQueney, P. A.; Bollag, D.; Lazarides, E. Taxol-induced mitotic block triggers rapid onset of a /753-independent apoptotic pathway. Mol Med 1:506-526; 1995.
33. Wyllie, A. H. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: An overview. Cancer Metastasis Rev. 11:95-103; 1992.
34. Yonish-Rouach, E.; Resnitzky, D.; Lotem, J.; Sachs, L.; Kimchi, A.; Oren, M. Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature 352:345-347; 1991.